PORTSMOUTH, N.H.--(BUSINESS WIRE)--Salient Surgical announced today that the company has completed the first human cases in Europe using its new AQUAMANTYS®3 System. The new system includes a handpiece that combines for the first time Salient’s patented TRANSCOLLATION® technology for hemostatic sealing of soft tissue and bones with cutting capabilities.
